Giorgio Parmiani spends much of his time researching Immunology, Antigen, Cytotoxic T cell, Cancer research and Melanoma. His Immunotherapy, T cell, T lymphocyte, Immune system and Antigen-presenting cell investigations are all subjects of Immunology research. His Antigen research includes themes of Human tumor, Antigen presentation and Cell biology.
His work deals with themes such as Epitope and Molecular biology, which intersect with Cytotoxic T cell. His studies deal with areas such as Cancer stem cell, Haematopoiesis and Cell culture, Epithelial cell adhesion molecule as well as Cancer research. His Melanoma research integrates issues from In vitro, Mutation, Gene, Metastasis and Peptide.
Giorgio Parmiani mainly investigates Immunology, Antigen, Melanoma, Molecular biology and Cytotoxic T cell. His work focuses on many connections between Immunology and other disciplines, such as Cancer research, that overlap with his field of interest in Cytokine. His research investigates the connection between Antigen and topics such as Transplantation that intersect with issues in Neoplasm and Fibrosarcoma.
Giorgio Parmiani focuses mostly in the field of Melanoma, narrowing it down to topics relating to Oncology and, in certain cases, Metastatic melanoma. Giorgio Parmiani focuses mostly in the field of Molecular biology, narrowing it down to matters related to In vitro and, in some cases, In vivo. His research in Cytotoxic T cell tackles topics such as T-cell receptor which are related to areas like T lymphocyte.
His primary areas of study are Immunology, Antigen, Immunotherapy, Cancer and Immune system. His studies in Immunology integrate themes in fields like Cytotoxic T cell and Cancer research, Melanoma. His Cancer research research incorporates themes from Cancer cell and Cancer stem cell.
His biological study spans a wide range of topics, including Lymphocyte and Immunogenicity. The various areas that Giorgio Parmiani examines in his Cancer study include Clinical trial and Family medicine. His work carried out in the field of Immune system brings together such families of science as Adjuvant and Antibody.
His main research concerns Immunology, Immunotherapy, Cancer, Antigen and Immune system. Giorgio Parmiani interconnects Cancer research, Clinical trial, CD44, Cancer stem cell and Cytotoxic T cell in the investigation of issues within Immunology. His Immunotherapy research is multidisciplinary, incorporating elements of Neo epitope and Clinical success.
His Cancer research includes elements of Melanoma and Oncology. The concepts of his Antigen study are interwoven with issues in Monocyte differentiation, Angiogenesis and Vaccination. His study in the field of T cell and Immunization is also linked to topics like Circulating microvesicle.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba;Scott J. Dylla;In Kyung Park;Rui Liu.
Proceedings of the National Academy of Sciences of the United States of America (2007)
A listing of human tumor antigens recognized by T cells.
Nicolina Renkvist;Chiara Castelli;Paul F. Robbins;Giorgio Parmiani.
Cancer Immunology, Immunotherapy (2001)
Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1
M Marchand;N van Baren;N van Baren;P Weynants;P Weynants;V Brichard;V Brichard;V Brichard.
International Journal of Cancer (1999)
Identification of a New Subset of Myeloid Suppressor Cells in Peripheral Blood of Melanoma Patients With Modulation by a Granulocyte-Macrophage Colony-Stimulation Factor–Based Antitumor Vaccine
Paola Filipazzi;Roberta Valenti;Veronica Huber;Lorenzo Pilla.
Journal of Clinical Oncology (2007)
Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles.
Giovanna Andreola;Licia Rivoltini;Chiara Castelli;Veronica Huber.
Journal of Experimental Medicine (2002)
A listing of human tumor antigens recognized by T cells: March 2004 update
Luisa Novellino;Chiara Castelli;Giorgio Parmiani.
Cancer Immunology, Immunotherapy (2005)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero;Gustav Gaudernack;Winald Gerritsen;Christoph Huber.
Nature Reviews Clinical Oncology (2014)
Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3
Marie Marchand;Patrick Weynants;Elaine Rankin;Flavio Arienti.
International Journal of Cancer (1995)
Cancer immunotherapy with peptide-based vaccines: what have we achieved? Where are we going?
Giorgio Parmiani;Chiara Castelli;Piero Dalerba;Roberta Mortarini.
Journal of the National Cancer Institute (2002)
Tumor-Released Microvesicles as Vehicles of Immunosuppression
Roberta Valenti;Veronica Huber;Manuela Iero;Paola Filipazzi.
Cancer Research (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: